Opinion: Making Cancer Vaccines Work

Armed with the right adjuvant system, vaccines are poised to tackle one of the world’s most intractable diseases.

Written byAbhishek Srivastava and Haval Shirwan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Electron micrograph of HPVWIKIMEDIA, NIH

More than four decades and billions of dollars since President Richard Nixon declared war on cancer, the disease is still the second most common cause of death in the U.S. According to American Cancer Society, nearly 600,000 Americans are expected to die of cancer in 2015, while more than 1.6 million new cancer cases are estimated to be diagnosed. Although we have learned much about the disease and improved outcomes for many patients, we are still relying on surgery, chemotherapy, and radiation to treat cancer, just as we did four decades ago. But, as widespread sequencing of tumors has revealed, no two cancers are identical, limiting the effectiveness of such homogenous treatment strategies.

One force partially equipped to address this magnitude of cancer diversity is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies